Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc.

NASDAQ:NVCT

Overview | Financials
Company Name Nuvectis Pharma, Inc.
Symbol NVCT
Currency USD
Price 6.95
Market Cap 127,574,617
Dividend Yield 0%
52-week-range 5.85 - 15.5
Industry Biotechnology
Sector Healthcare
CEO Mr. Ron Bentsur M.B.A.
Website https://www.nuvectis.com

An error occurred while fetching data.

About Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the

Related Stocks

Kamada Ltd. logo

Kamada Ltd.

KMDA

4.23 USD

Alpha Teknova, Inc. logo

Alpha Teknova, Inc.

TKNO

3.27 USD

Altimmune, Inc. logo

Altimmune, Inc.

ALT

6.27 USD

XOMA Corporation logo

XOMA Corporation

XOMA

28.23 USD

G1 Therapeutics, Inc. logo

G1 Therapeutics, Inc.

GTHX

3.73 USD

Sutro Biopharma, Inc. logo

Sutro Biopharma, Inc.

STRO

3.89 USD

Semler Scientific, Inc. logo

Semler Scientific, Inc.

SMLR

32.93 USD

Entrada Therapeutics, Inc. logo

Entrada Therapeutics, Inc.

TRDA

16.17 USD

Accuray Incorporated logo

Accuray Incorporated

ARAY

1.94 USD

Financials

Numbers are in millions USD

Numbers are in millions USD